Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 85
Filtrar
1.
Pediatr Dermatol ; 38 Suppl 2: 20-29, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34664330

RESUMO

Dermatology for the pediatric skin of color population is the application of dermatology to the genetically diverse and distinctive segment of the pediatric population that includes children of non-White racial and ethnic groups with increased pigmentation including individuals of Asian, LatinX, African, Native American, Pacific Island descent, Indigenous Peoples, among others, with overlap in particular individuals, and mixtures thereof. Treating children of color is a unique skill set within the field of pediatric dermatology, requiring knowledge and sensitivity. The discipline of pediatric skin of color can be challenging. Difficulty in diagnosis of common conditions stems from underlying pigmentation, variations in common hairstyling practices, and differences in demographics of cutaneous disease, whereas some conditions are more common in children of color, other conditions have nuances in clinical appearance and/or therapeutics with regard to skin color. This article is the first in a series of two articles looking at recently published skin-related issues of high concern in children of color. Conditions reviewed in Part 1 include (1) hairstyling hair-related concerns (traction alopecia, central centrifugal cicatricial alopecia, endocrine disruption), (2) autoimmune concerns (cutaneous lupus, vitiligo), and (3) infections (tinea capitis, progressive macular hypomelanosis).


Assuntos
Dermatopatias , Pigmentação da Pele , Alopecia , Criança , Cabelo , Humanos , Pele , Dermatopatias/diagnóstico
2.
Pediatr Dermatol ; 38 Suppl 2: 30-36, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34708446

RESUMO

Dermatology for pediatric skin of color is the application of dermatology to the genetically diverse and distinctive segment of the pediatric population that includes children of non-White racial and ethnic groups with increased pigmentation including individuals of Asian, Hispanic/LatinX, African, Native American, Pacific Island descent, indigenous people among others with overlap in particular individuals, and mixtures thereof. The discipline of pediatric skin of color can be challenging with difficulty in diagnosis of common conditions due to underlying pigmentation, variations in common hair styling practices, and differences in demographics of cutaneous disease. Whereas some conditions are more common in children of color, other conditions have nuances in clinical appearance and therapeutics with regard to skin color. This article, the second of the series, focuses on inflammatory skin disease nuances, melanocytic disorders, and hypopigmented mycosis fungoides.


Assuntos
Transtornos da Pigmentação , Dermatopatias , Criança , Etnicidade , Humanos , Pele , Dermatopatias/diagnóstico , Pigmentação da Pele
3.
F1000Res ; 10: 148, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34164111

RESUMO

Neurofibromatosis 1 (NF1) is a neurocutaneous syndrome characterized by multiple café-au-lait macules, cutaneous neurofibromas or plexiform neurofibromas, iris Lisch nodules, axillary and inguinal freckling. Mosaicism in NF1 can either present as a generalized disease, or in a localized (segmental) manner. Mosaic generalized NF1 may have presentations that are similar to generalized NF1 or have a milder phenotype and hence may be under-recognised in clinical practice. We report a nonsense mutation in the NF1 gene in a 55-year old Chinese male with the mosaic generalized phenotype. He reported noticing increasing numbers of skin-colored papules over his face, neck, back and abdomen when he was about 40 years old. From both next-generation and Sanger sequencing data, the variant appeared to be mosaic and present at about 24%. It is in exon 39 and has not been reported in any database or published literature.


Assuntos
Neurofibromatose 1 , Neurofibromina 1 , Adulto , Códon sem Sentido , Genes da Neurofibromatose 1 , Humanos , Masculino , Pessoa de Meia-Idade , Mosaicismo , Neurofibromatose 1/genética , Neurofibromina 1/genética , Fenótipo
4.
7.
Dermatol Ther (Heidelb) ; 11(1): 275-291, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33313998

RESUMO

INTRODUCTION: There is some evidence to suggest that the prevalence of atopic dermatitis (AD) in Asia is rising. We have therefore developed an algorithm for the topical treatment of AD throughout South and East Asia for use by primary care physicians, pediatricians and dermatologists. METHODS: Nine AD experts from South and East Asia and one from Europe developed the algorithm based upon treatment guidelines, relevant literature and local treatment practices. The algorithm outlines current best practice for the use of emollients, topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI), with the intention of simplifying the treatment regimen of mild-to-moderate AD in South and East Asia. RESULTS: Patients with AD should bathe and cleanse affected skin to remove crusts and scales daily. Emollients should also be applied daily as a maintenance treatment. When selecting appropriate topical anti-inflammatory treatment for AD flares, several factors should be taken into consideration, including the patient's age, attitude to treatment options and site of AD lesions. Given the concerns regarding the risk of skin atrophy with use of TCS, a TCI should be used to treat AD lesions in sensitive skin areas: pimecrolimus is recommended for mild-to-moderate AD in these locations, while tacrolimus should be considered for moderate and severe cases. Either pimecrolimus or tacrolimus is recommended for flares in other, non-sensitive body locations. A proactive or intermittent maintenance treatment strategy involving regular emollient use and twice-weekly application of a TCI to previously affected areas is encouraged to reduce the risk of flares. CONCLUSIONS: The algorithm proposed here is intended to simplify the topical treatment of mild-to-moderate AD in daily practice in South and East Asian countries.

9.
Clin Case Rep ; 7(10): 1982-1983, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31624622

RESUMO

Clinicians should be aware that cutaneous PAN can present with significant extracutaneous and constitutional symptoms which make it hard to differentiate from systemic PAN. The condition can also rarely be associated with NTM infections.

11.
JAAD Case Rep ; 4(4): 283-285, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29693048
13.
Pharmacogenomics ; 18(9): 881-890, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28594314

RESUMO

The Health Sciences Authority launched a pharmacogenetics initiative in 2008 to facilitate evaluation of pharmacogenetics associations pertinent for Chinese, Malays and Indians in Singapore. The aim was to reduce the incidence and unpredictability of serious adverse drug reactions, with a focus on serious skin adverse drug reactions. This paper describes the gathering of evidence and weighing of factors that led to different genotyping recommendations for HLA-B*15:02 with carbamazepine and HLA-B*58:01 with allopurinol, despite both having strong genetic associations. Translation of pharmacogenomics at a national level requires careful deliberation of the prevalence of at-risk allele, strength of genetic associations, positive predictive value, cost-effectiveness and availability of alternative therapies. Our experience provides a perspective on translating genomic discoveries in advancing drug safety.


Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/genética , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/prevenção & controle , Dermatopatias/induzido quimicamente , Pele/efeitos dos fármacos , Alelos , Alopurinol/efeitos adversos , Carbamazepina/efeitos adversos , Análise Custo-Benefício/métodos , Antígenos HLA-B/genética , Humanos , Farmacogenética/métodos , Singapura , Dermatopatias/genética
14.
Dermatol Clin ; 35(3): 395-402, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28577807

RESUMO

Atopic dermatitis (AD) is a common, chronic inflammatory skin condition affecting up to 20% of children and 3% of adults worldwide. There is wide variation in the prevalence of AD among different countries. Although the frequency of AD is increasing in developing countries, it seems to have stabilized in developed countries, affecting approximately 1 in 5 schoolchildren. Adult-onset AD is not uncommon and is significantly higher, affecting between 11% and 13% of adults in some countries, for example, Singapore, Malaysia, and Sweden. AD is thus associated with significant health care economic burden in all age groups.


Assuntos
Dermatite Atópica/etnologia , Disparidades nos Níveis de Saúde , Fatores Etários , China/epidemiologia , Dermatite Atópica/diagnóstico , Dermatite Atópica/genética , Dermatite Atópica/patologia , Humanos , Malásia/epidemiologia , Fenótipo , Prevalência , Singapura/epidemiologia , Fatores Socioeconômicos , Suécia/epidemiologia
15.
Pediatr Dermatol ; 34(4): 492-493, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28543755

RESUMO

This report compares the efficacy of timolol maleate 0.5% eyedrops (TM) with that of timolol maleate 0.5% ophthalmic gel-forming solution in the treatment of infantile hemangiomas (IHs). Sixty-six patients undergoing treatment with topical timolol were retrospectively reviewed; our results revealed similar therapeutic efficacies for both types of timolol formulations. Early treatment initiation (<3 mos) and superficial lesions correlated with better treatment response. TM eyedrops may be a more cost effective, equally efficacious modality of treatment for IHs.


Assuntos
Antagonistas Adrenérgicos beta/administração & dosagem , Hemangioma/tratamento farmacológico , Neoplasias Cutâneas/tratamento farmacológico , Timolol/administração & dosagem , Administração Tópica , Humanos , Lactente , Soluções Oftálmicas/administração & dosagem , Estudos Retrospectivos , Resultado do Tratamento
16.
JAAD Case Rep ; 3(2): 100-102, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28361109
17.
Ann Acad Med Singap ; 45(10): 439-450, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27832218

RESUMO

INTRODUCTION: Atopic dermatitis is a common, chronic pruritic condition affecting both children and adults, which has a negative impact on the quality of life. These guidelines were developed by an expert workgroup appointed by the Dermatological Society of Singapore, to provide doctors with information to assist in the management of their patients with atopic dermatitis. The workgroup members are experienced dermatologists with interest and expertise in eczemas. MATERIALS AND METHODS: Workgroup members arrived at a consensus on the topics to be included. Relevant studies from the literature were assessed for best evidence, supplemented by the collective experience of the workgroup. RESULTS: For mild atopic dermatitis, emollients, mild potency topical steroids and topical calcineurin inhibitors are recommended. For moderate-to-severe atopic dermatitis, the use of emollients, moderate-to-potent topical steroids, topical calcineurin inhibitors, wet dressings, antimicrobials for secondary skin infection, phototherapy, and systemic therapy (e.g. prednisolone, cyclosporine, azathioprine or methotrexate) may be warranted. Patients with moderate-to-severe atopic dermatitis should be managed in conjunction with a dermatologist. CONCLUSION: Good outcomes can be achieved with an individualised therapeutic approach combined with adequate patient and parental education.


Assuntos
Corticosteroides/uso terapêutico , Inibidores de Calcineurina/uso terapêutico , Dermatite Atópica/terapia , Emolientes/uso terapêutico , Imunossupressores/uso terapêutico , Fototerapia , Administração Cutânea , Antibacterianos/uso terapêutico , Azatioprina/uso terapêutico , Coinfecção/complicações , Coinfecção/tratamento farmacológico , Ciclosporina/uso terapêutico , Dermatite Atópica/complicações , Dermatite Atópica/imunologia , Dermatologia , Gerenciamento Clínico , Hipersensibilidade Alimentar/imunologia , Humanos , Metotrexato/uso terapêutico , Educação de Pacientes como Assunto , Guias de Prática Clínica como Assunto , Encaminhamento e Consulta , Índice de Gravidade de Doença , Singapura
19.
JAAD Case Rep ; 2(1): 10-2, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27051814
20.
Pediatr Dermatol ; 32(4): 488-94, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25845296

RESUMO

BACKGROUND: Nontuberculous mycobacterium (NTM) infections are rare in children, with limited published studies. The course of the disease can be variable and there are no accepted treatment guidelines for the management of NTM infections in children. OBJECTIVE: To review a cohort of pediatric patients admitted to a tertiary pediatric hospital in Singapore for cutaneous NTM infections. METHODS: A retrospective review was performed of all children admitted to KK Women's and Children's Hospital with cutaneous NTM infections from 2002 to 2012. RESULTS: Sixty-seven patients with positive NTM cultures from various body sites were identified. Eight of the 67 patients (11.9%) presented with cutaneous NTM without evidence of systemic involvement. The mean age at diagnosis for these eight patients was 10 years (range 5-21 yrs). Mycobacterium abscessus was the most common NTM isolated (five patients), followed by Mycobacterium hemophilium (two patients) and Mycobacterium kansasii (one patient). Most patients presented with isolated skin abscesses. Two patients were immunocompromised. Six patients required multidrug antibiotic treatment for a median duration of 5.5 months (range 3-17 mos). The median follow-up duration was 8.5 months (range 2 wks-29 mos). CONCLUSION: Although the incidence of cutaneous NTM is rare, the diagnosis should be considered in patients presenting with chronic wounds. Most patients require treatment with multidrug antibiotic therapy, although uncomplicated abscesses can be treated with surgical incision and drainage alone.


Assuntos
Infecções por Mycobacterium não Tuberculosas/epidemiologia , Dermatopatias Infecciosas/epidemiologia , Dermatopatias Infecciosas/microbiologia , Adolescente , Antituberculosos/uso terapêutico , Criança , Pré-Escolar , Quimioterapia Combinada , Feminino , Humanos , Masculino , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Estudos Retrospectivos , Singapura/epidemiologia , Dermatopatias Infecciosas/tratamento farmacológico , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...